Found 5 matching trials
A Study of INCMGA00012, INCB001158, and the Combination in Japanese Participants With Advanced Solid Tumors PHASE1 The purpose of this study is to assess the safety and tolerability and the ...
Show More Location
National Cancer Center Hospital
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid Tumors PHASE1 The purpose of this study is to assess the safety and antitumor activity of...
Show More Location
University of Alabama
Learn More & Join Trial
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors PHASE1 The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate...
Show More Location
University of Alabama
Learn More & Join Trial
INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma PHASE1 The purpose of this study is to evaluate the safety and antitumor activity ...
Show More Location
Southern Cancer Center
Learn More & Join Trial
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors PHASE1 This study is an open-label Phase 1/Phase 2 evaluation of INCB001158 as a s...
Show More Location
University of South Alabama
Learn More & Join Trial